Fermi Inc (FRMI)

NASDAQReal EstateReit - SpecialtySnapshot 2026-10-26

$2.54-0.39%

Close 2026-10-26 · 1-day change

Investment OutlookAs of Oct 26, 2026

What could strengthen or challenge Fermi Inc’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Oct 4, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

Comparable estimates unavailable

+10% or more+5%0%−5%−10% or less

A matching fiscal period and sufficient coverage are required.

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	12.63M
EPS	—	-0.038
Annual ending 2026-12-31
Revenue	—	7.58M
EPS	—	-0.394
Annual ending 2027-12-31
Revenue	—	402.78M
EPS	—	0.065

Management figures unavailable.

What the Thesis Depends On

Three published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Effective management of capital allocation	A supporting condition in Fermi Inc's published investment case. The stated target is Maintain share buyback program and manage convertible notes effectively.	Under Pressure	failure to execute share buyback or mismanagement of convertible notes	Qualitative: Negative capital allocation event (Direct Financial Obligation) reported 2026-07-15 July 2026 filing disclosed creation of a direct financial obligation, flagged as negative for capital allocation. Context reviewed through Oct 26, 2026Last status assessment Oct 26, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 2 of last 6 quarters. Management issued $375 million convertible senior notes in 2026-Q3 and announced a share buyback program. The capital allocation strategy is active but with limited quarters disclosed, progress is ongoing. Delivery assessment Oct 26, 2026
Stability in executive leadership	A supporting condition in Fermi Inc's published investment case. The stated target is No further significant executive departures.	Intact	another significant executive departure occurs	0 significant executive departures vs 0 allowed Recent filings show CEO internal promotion and new CFO hire. No senior executive departures reported in the last 4 quarters. Context reviewed through Oct 26, 2026Last status assessment Oct 26, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 3 of last 6 quarters. Management completed CEO internal promotion and CFO appointments in 2026-Q2 and Q3. These leadership transitions are recent and ongoing, reflecting active management of executive talent. Delivery assessment Oct 26, 2026
Operating income must continue to improve	is improving its operating income, reducing losses significantly.	Intact	operating income worsens beyond -$30 million next quarter	Operating income: $-26.759M FY2026-Q2; GAAP. Published target: >= -$26.8 million. Target period is not explicitly aligned with this observation. Source published Aug 14, 2026-26,759,000 USD · source valueSource reportLast status assessment Oct 26, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: d766515a-96cf-4299-a5a4-b73e082ffaff. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 6 of last 6 quarters. Operating income improved significantly from -$134.3M in 2025-Q4 to -$26.8M in 2026-Q2, and net losses reduced from -$346.8M in 2025-Q3 to -$25.8M in 2026-Q2. The trajectory shows delivering progress on improving operating income and reducing net losses. Delivery assessment Oct 26, 2026

Stored thesis · Oct 4, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS: comparable history unavailable.

FY2027 revenueUnavailable

$0.46B → Unavailable · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-09-07	Unavailable	$457,455,977	3 / 5
2026-09-08	Unavailable	$457,455,977	3 / 5
2026-09-09	Unavailable	$457,455,977	3 / 5
2026-09-10	Unavailable	$457,455,977	3 / 5
2026-09-11	Unavailable	$457,455,977	3 / 5
2026-09-12	Unavailable	$457,455,977	3 / 5
2026-09-13	Unavailable	$457,455,977	3 / 5
2026-09-14	Unavailable	$457,455,977	3 / 5
2026-09-15	Unavailable	$457,455,977	3 / 5
2026-09-16	Unavailable	$457,455,977	3 / 5
2026-09-17	Unavailable	$457,455,977	3 / 5
2026-09-18	Unavailable	$457,455,977	3 / 5
2026-09-19	Unavailable	$457,455,977	3 / 5
2026-09-20	Unavailable	$457,455,977	3 / 5
2026-09-21	Unavailable	$457,455,977	3 / 5
2026-09-22	Unavailable	$457,455,977	3 / 5
2026-09-23	Unavailable	$457,455,977	3 / 5
2026-09-24	Unavailable	$457,455,977	3 / 5
2026-09-25	Unavailable	$457,455,977	3 / 5
2026-09-26	Unavailable	$457,455,977	3 / 5
2026-09-27	Unavailable	Unavailable	3 / 4
2026-09-28	Unavailable	Unavailable	3 / 4
2026-09-29	Unavailable	Unavailable	3 / 4
2026-09-30	Unavailable	Unavailable	3 / 4
2026-10-01	Unavailable	Unavailable	3 / 4
2026-10-02	Unavailable	Unavailable	3 / 4
2026-10-03	Unavailable	Unavailable	3 / 4
2026-10-04	Unavailable	Unavailable	3 / 4
2026-10-05	Unavailable	Unavailable	3 / 4
2026-10-06	Unavailable	Unavailable	3 / 4
2026-10-07	Unavailable	Unavailable	3 / 4
2026-10-08	Unavailable	Unavailable	3 / 4
2026-10-09	Unavailable	Unavailable	3 / 4
2026-10-10	Unavailable	Unavailable	3 / 4
2026-10-11	Unavailable	Unavailable	3 / 4
2026-10-12	Unavailable	Unavailable	3 / 4
2026-10-13	Unavailable	Unavailable	3 / 4
2026-10-14	Unavailable	Unavailable	3 / 4
2026-10-15	Unavailable	Unavailable	3 / 4
2026-10-16	Unavailable	Unavailable	3 / 4
2026-10-17	Unavailable	Unavailable	3 / 4
2026-10-18	Unavailable	Unavailable	2 / 4
2026-10-19	Unavailable	Unavailable	2 / 4
2026-10-20	Unavailable	Unavailable	2 / 4
2026-10-21	Unavailable	Unavailable	2 / 4
2026-10-22	Unavailable	Unavailable	2 / 4
2026-10-23	Unavailable	Unavailable	2 / 4
2026-10-24	Unavailable	Unavailable	2 / 4
2026-10-25	Unavailable	Unavailable	2 / 4
2026-10-26	Unavailable	Unavailable	2 / 4

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	9	2
2026-06-01	6	2
2026-07-01	6	2
2026-08-01	6	2
2026-09-01	6	2
2026-10-01	6	2

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 6 Buy / Strong Buy · 2 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades2 maintains

Recent actions · Sep 27–Oct 26 · 2 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 27, 2026–Oct 26, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Effective management of capital allocationPublished status: Under Pressure
Operating income must continue to improveOperating income: $-26.759M

Next proof point

Nov 12, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

4.5%Typical daily move · historical

Downside history

-91.5%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Fermi Inc outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a loss-making, higher-risk real estate growth story, not a proven durable compounder. The thesis is in a watch state: management has made progress reducing losses, but the new lease has not yet shown a delivery record.

What's priced into Fermi Inc

The evidence provides no valuation level or clear account of what the market already assumes, so the expectations gap is hard to judge. The valuation model has high confidence, but the business remains loss-making and overall evidence confidence is low.

What the fundamentals likely do

Over the recent quarters, operating income improved and net losses narrowed, though performance remains weak relative to the industry cohort and recent earnings have been erratic. Near term, another earnings miss is a meaningful risk; the CEO and CFO transitions also add uncertainty, while the TensorWave lease is planned to begin phased delivery in Q4 2027.

What Fermi Inc hinges on

The multi-year thesis depends on FRMI delivering the binding 15-year TensorWave lease as planned and sustaining progress toward lower losses. Near-term sector conditions may help or hinder: Fed rate cuts and strong results from EQIX, AMT, and DLR are favorable signals, while weaker results or guidance from those peers could remove a sector tailwind.